| Immune reconstitution and survival of 100 SCID patients post–hematopoietic cell transplant: a PIDTC natural history study J Heimall, BR Logan, MJ Cowan, LD Notarangelo, LM Griffith, JM Puck, ... Blood, The Journal of the American Society of Hematology 130 (25), 2718-2727, 2017 | 236 | 2017 |
| Family-centered multidisciplinary rounds enhance the team approach in pediatrics P Rosen, E Stenger, M Bochkoris, MJ Hannon, CK Kwoh Pediatrics 123 (4), e603-e608, 2009 | 169 | 2009 |
| Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity EO Stenger, HR Turnquist, MY Mapara, AW Thomson Blood, The Journal of the American Society of Hematology 119 (22), 5088-5103, 2012 | 142 | 2012 |
| Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies CE Allen, R Marsh, P Dawson, CM Bollard, S Shenoy, P Roehrs, R Hanna, ... Blood, The Journal of the American Society of Hematology 132 (13), 1438-1451, 2018 | 96 | 2018 |
| Chronic granulomatous disease-associated IBD resolves and does not adversely impact survival following allogeneic HCT RA Marsh, JW Leiding, BR Logan, LM Griffith, DE Arnold, E Haddad, ... Journal of clinical immunology 39, 653-667, 2019 | 44 | 2019 |
| Immune tolerance strategies in siblings with infantile Pompe disease—Advantages for a preemptive approach to high-sustained antibody titers EO Stenger, Z Kazi, E Lisi, MJ Gambello, P Kishnani Molecular genetics and metabolism reports 4, 30-34, 2015 | 31 | 2015 |
| Hematopoietic stem cell transplantation to treat leukodystrophies: clinical practice guidelines from the hunter's hope leukodystrophy care network KM Page, EO Stenger, JA Connelly, D Shyr, T West, S Wood, L Case, ... Biology of Blood and Marrow Transplantation 25 (12), e363-e374, 2019 | 27 | 2019 |
| Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders RA Marsh, K Hebert, S Kim, CC Dvorak, VM Aquino, KS Baker, ... Journal of Allergy and Clinical Immunology 149 (3), 1097-1104. e2, 2022 | 23 | 2022 |
| IL-12hi Rapamycin-Conditioned Dendritic Cells Mediate IFN-γ–Dependent Apoptosis of Alloreactive CD4+ T Cells In Vitro and Reduce Lethal Graft-Versus-Host Disease EO Stenger, BR Rosborough, LR Mathews, H Ma, MY Mapara, ... Biology of Blood and Marrow Transplantation 20 (2), 192-201, 2014 | 21 | 2014 |
| Bone marrow–derived mesenchymal stromal cells from patients with sickle cell disease display intact functionality EO Stenger, R Chinnadurai, S Yuan, M Garcia, D Arafat, G Gibson, ... Biology of Blood and Marrow Transplantation 23 (5), 736-745, 2017 | 20 | 2017 |
| Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders MT Vander Lugt, X Chen, ML Escolar, BA Carella, JL Barnum, ... Blood advances 4 (13), 3041-3052, 2020 | 19 | 2020 |
| High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia BJ Dávila Saldaña, T John, C Bonifant, D Buchbinder, S Chandra, ... Blood advances 6 (2), 452-459, 2022 | 14 | 2022 |
| How I treat sickle cell disease with hematopoietic cell transplantation EO Stenger, S Shenoy, L Krishnamurti Blood, The Journal of the American Society of Hematology 134 (25), 2249-2260, 2019 | 11 | 2019 |
| Mesenchymal stromal cells to modulate immune reconstitution early post-hematopoietic cell transplantation EO Stenger, L Krishnamurti, J Galipeau BMC immunology 16, 1-10, 2015 | 10 | 2015 |
| Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure EO Stenger, B Watkins, K Rogowski, KY Chiang, A Haight, K Leung, ... Blood Advances 7 (10), 2196-2205, 2023 | 8 | 2023 |
| Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease E Stenger, CR Giver, A Langston, D Kota, PK Das, R Chinnadurai, ... Frontiers in Immunology 13, 959658, 2022 | 8 | 2022 |
| Development of a multi-center cohort to evaluate long-term outcomes and late effects following hematopoietic cell transplantation for sickle cell disease: a STAR Initiative E Stenger, A Abraham, CD Travers, HG Rangarajan, D Hsu, S Chaudhury, ... Blood 130, 3271, 2017 | 7 | 2017 |
| Sickle Cell Transplantation Evaluation of Long-term and Late Effects Registry (STELLAR) to compare long-term outcomes after hematopoietic cell transplantation to those in … L Krishnamurti, SD Arnold, A Haight, A Abraham, GMT Guilcher, T John, ... JMIR Research Protocols 11 (7), e36780, 2022 | 6 | 2022 |
| Poor T cell reconstitution at 100 days after T cell-replete hematopoietic cell transplantation (HCT) for SCID is associated with later risk of death or need for 2nd transplant … J Heimall, BR Logan, MJ Cowan, LD Notarangelo, J Puck, T Fleisher, ... Biology of Blood and Marrow Transplantation 22 (3), S101-S102, 2016 | 6 | 2016 |
| Use of alefacept for preconditioning in multiply transfused pediatric patients with nonmalignant diseases EO Stenger, KY Chiang, A Haight, M Qayed, L Kean, J Horan Biology of Blood and Marrow Transplantation 21 (10), 1845-1852, 2015 | 6 | 2015 |
